Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Roferon-A
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Roferon-A 18million units/0.5ml inj pre-filled syringes
0802040J0BCAQBG
|
Roferon-A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Roferon-A 18million units/0.6ml inj cartridges
0802040J0BCAPBF
|
Roferon-A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Roferon-A 3million units/0.5ml inj pre-filled syringes
0802040J0BCAJAV
|
Roferon-A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Roferon-A 4.5million units/0.5ml inj pre-filled syringes
0802040J0BCAKAW
|
Roferon-A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Roferon-A 6million units/0.5ml inj pre-filled syringes
0802040J0BCALAX
|
Roferon-A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Roferon-A 9million units/0.5ml inj pre-filled syringes
0802040J0BCAMAY
|
Roferon-A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.